Slowly the tune is a changing.
Globe and Mail- Doctors concerned they can’t access COVID-19 treatments that can prevent hospitalizations
Health Canada has authorized a handful of treatments called monoclonal antibodies that can reduce severe illness when given to people within a few days of symptom onset. However, treatment with monoclonal antibodies, which must be administered intravenously, is not widely available to those who would benefit most in many parts of Canada, according to Andrew Morris. “It’s almost random how people can get access to it,” said Dr. Morris, who is also a member of Ontario’s COVID-19 Science Advisory Table. “Most doctors and other health care providers have no idea how to access it.”
CBC- Alberta rolls out its first outpatient COVID-19 treatment as experts warn it’s not a vaccine substitute
Alberta began a phased roll-out on Tuesday which initially includes people 65 and over who test positive but have not received any doses of the COVD-19 vaccine as well as solid organ transplant and stem cell transplant recipients who are COVID-positive regardless of their vaccination status. Community paramedics administer the IV therapy in patients’ homes in regions where these teams are in place. The treatment will be offered in an Alberta Health Services clinic for people living in the Fort McMurray area.
CTV- ‘Good news,’ says doctor: Some Quebec COVID-19 patients to soon have access to monoclonal antibody treatment
CBC- Sask. has treated 6 people with monoclonal antibodies for COVID-19, despite hundreds of available doses
Francisco- If they really wanted to put a dent in the seasonal winter surge they’d be telling everyone to load up on Vitamin D and allowing them access to already proven outpatient treatments. But no, the maniacs in charge are still trying to dazzle us with their “brilliance”.
Beginning Saturday, November 13 at 12:01 am, religious gatherings in this region will be limited to 25 persons unless the facility can physically divide their space into separate areas, in which case there can be several cohorts of 25 people. The total number of attendees can not exceed 25 per cent capacity to a maximum of 250 people.